Role of Bcl‐2 inhibition in myelodysplastic syndromes
S Blum, G Tsilimidos, H Bresser… - International Journal of …, 2023 - Wiley Online Library
Myelodysplasic syndromes (MDS) are diseases occurring mainly in the elderly population.
Although hematopoietic stem cell transplantation is the only hope for cure, a majority of the …
Although hematopoietic stem cell transplantation is the only hope for cure, a majority of the …
[HTML][HTML] Survival improvement over Time of 960 s-AML patients included in 13 EORTC-GIMEMA-HOVON trials
SM Ramadan, S Suciu, MJPL Stevens-Kroef… - Cancers, 2020 - mdpi.com
Simple Summary Secondary acute myeloid leukemia (s-AML) refers to the development of
AML following myelodysplatic syndrome or other hematological malignancies, or after a …
AML following myelodysplatic syndrome or other hematological malignancies, or after a …
Myelodysplastic syndromes
PL Greenberg, E Attar, JM Bennett… - Journal of the National …, 2013 - jnccn.org
The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal
hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid …
hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid …
Standard therapy for patients with myelodysplastic syndromes
A Al-Ameri, M Cherry, G Garcia-Manero… - … Myeloma and Leukemia, 2011 - Elsevier
The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell
disorders characterized by cytopenias, dysplastic changes in the hematopoietic precursors …
disorders characterized by cytopenias, dysplastic changes in the hematopoietic precursors …
Hemopoietic cell transplantation as curative therapy of myelodysplastic syndromes and myeloproliferative disorders
B Scott, HJ Deeg - Best Practice & Research Clinical Haematology, 2006 - Elsevier
Hemopoietic cell transplantation (HCT) is presently the only therapy with curative potential
for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD). Among …
for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD). Among …
Hematopoietic cell transplantation for adult patients with myelodysplastic syndromes and myeloproliferative disorders
M Benesch, HJ Deeg - Mayo Clinic Proceedings, 2003 - Elsevier
Hematopoietic cell transplantation (HCT) is currently the only treatment with curative
potential for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD) …
potential for myelodysplastic syndromes (MDS) and myeloproliferative disorders (MPD) …
[HTML][HTML] Cost-effectiveness of posaconazole tablets for invasive fungal infections prevention in acute myelogenous leukemia or myelodysplastic syndrome patients in …
Introduction Posaconazole is superior to fluconazole (FLU) and itraconazole (ITRA) in the
prevention of invasive fungal diseases (IFDs) in neutropenic patients with acute …
prevention of invasive fungal diseases (IFDs) in neutropenic patients with acute …
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
T Hamaki, M Kami, SW Kim, Y Onishi, Y Kishi… - Bone marrow …, 2004 - nature.com
The purpose of this study was to evaluate the feasibility and efficacy of allogeneic
hematopoietic stem cell transplantation with a reduced-intensity regimen (RIST) in patients …
hematopoietic stem cell transplantation with a reduced-intensity regimen (RIST) in patients …
Thalidomide for the treatment of myelodysplastic syndrome in Taiwan: results of a phase II trial
CY Chung, SF Lin, PM Chen, MC Chang… - Anticancer …, 2012 - ar.iiarjournals.org
Background: Thalidomide inhibits angiogenesis and exerts complex immunomodulatory
activities. This phase II study aimed to examine the efficacy of thalidomide in Taiwanese …
activities. This phase II study aimed to examine the efficacy of thalidomide in Taiwanese …
Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes
ED Warlick, PV O'Donnell, M Borowitz, N Grupka… - Leukemia research, 2008 - Elsevier
Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment
for patients with myelodysplastic syndromes (MDS), but its application has been limited by …
for patients with myelodysplastic syndromes (MDS), but its application has been limited by …